FGFR2 Receptor Drives EBV-Linked Lymphoma, Suggesting Targeted Therapy Pathway
Virus-driven cancers account for roughly 15–20% of all human malignancies worldwide, yet targeted treatment options remain limited. A finding that a single…
Found 2067 results for "cancer"
Virus-driven cancers account for roughly 15–20% of all human malignancies worldwide, yet targeted treatment options remain limited. A finding that a single…
One of the most persistent frustrations in oncology is watching a chemotherapy drug fail not because cancer cells are inherently resistant, but because the…
One of biology's most enduring metaphors — cells rolling down hills toward their developmental destiny — has now been translated into a predictive…
Most medical models assume that average disease burden predicts average outcomes — but this mathematical framework challenges that assumption in a way that…
Lung cancer remains the leading cause of cancer mortality worldwide, yet the blunt instrument of age-plus-pack-year criteria misses a substantial proportion…
Amino acid metabolism sits at the intersection of nutrition and oncology in ways that could reshape how clinicians stratify cancer risk and personalize…
Emerging preclinical and observational evidence positions semaglutide and tirzepatide — GLP-1 and dual GIP/GLP-1 receptor agonists — as multi-system…
For the substantial population of lung cancer patients whose tumors stop responding to targeted therapies, treatment options have historically offered…
For the roughly one-third of Asian lung cancer patients — and a meaningful share globally — whose tumors carry EGFR mutations, disease progression after…
Understanding why glioblastoma remains almost universally fatal despite treatment requires better laboratory models — and a subtle but consequential variable…
Most antiviral drugs are built around a fundamental vulnerability: they target the virus directly, which means a single mutation can render them useless. A…
The idea that chronic psychological or physiological stress accelerates aging has long circulated in lay health culture, but the molecular machinery…
Understanding why children raised on farms develop asthma at dramatically lower rates than urban peers has been one of immunology's most productive puzzles…
Pain management after breast cancer treatment sits at a difficult intersection: undertreated pain undermines quality of life and recovery, while prolonged…
Uterine cancer is the most common gynecologic malignancy in the United States, yet its environmental drivers remain poorly characterized compared with breast…
PET117, a conserved mitochondrial protein, is significantly overexpressed in cervical cancer tissue and acts as a pro-ferroptotic regulator. Knocking out…
Mental health rarely commands the same urgency as cardiovascular disease or cancer in public health investment decisions, yet the scale of depression's…
Drug resistance remains one of the most frustrating obstacles in oncology, and for the millions of patients with advanced lung cancer, it can mean the…
Despite decades of public health messaging linking ultraviolet radiation to melanoma and non-melanoma skin cancers, a substantial portion of the American…
A biomarker hiding in plain sight on routine cancer scans may carry prognostic information that oncologists have largely overlooked. Every PET/CT performed…